Becton Dickinson said it would focus on medtech and prioritize research, acquisitions and high-growth markets.

Chief Executive Tom Polen said he believes the separation would help differentiate BD in the medical-technology industry, and allow the company to invest more in innovation and margin growth.

Activist Starboard took a position in Becton Dickinson, calling for the company to sell its life sciences business. The ...

(This Feb. 5 story has been refiled to correct the name of the unit to biosciences and diagnostic solutions, from life sciences, in the headline and paragraphs 1 and 4) (Reuters) - Becton Dickinson ...

FRANKLIN LAKES, N.J. (AP) — FRANKLIN LAKES, N.J. (AP) — Becton Dickinson and Co. (BDX) on Wednesday reported fiscal first-quarter earnings of $303 million. On a per-share basis, the Franklin ...

BofA analyst Travis Steed raised the firm’s price target on Becton Dickinson (BDX) to $269 from $265 and keeps a Buy rating on the shares after ...

Becton, Dickinson and Company (BDX, Financials) announced a major strategic shift with plans to separate its Biosciences and Diagnostic Solutions unit, aiming to create two independent ...